Change Experts Academy
Our First Offering will focus on transforming lives through Ethical Ketamine Treatment.
"Unlocking Katamine for Suicidal Prevention"
is the first offering from Change Experts Academy targeting medical professionals interested in learning about using ketamine as a medication. Suicidal Ideation reduction has been demonstrated with ketamine for decades.
The current literature supports ketamine’s rapid reduction in suicidal ideation. Long-term prevention outcomes are underfunded—not disproven.
Esketamine was recently FDA-approved for Major Depression with Suicidal Ideation, regardless of whether the client qualifies for Multi-Drug Resistant Depression diagnosis (Also Called Treatment Resistant Depression).
And yet, our standard responses remain:
Call 911
Admit involuntarily (5150)
Delay care
Add another medication that takes weeks to months for effect
Ask patients to “contract for safety.”
These interventions often reduce provider anxiety, while leaving the patient’s internal experience unchanged.
Patients report additional trauma from the "support response", often become conditioned to be dishonest and hide their feelings because they want to avoid the trauma of our current standard response.
This gap is where lives are lost.
Ketamine changes the narrative for current suicide prevention coordinated care that is patient-centered and focused on helping clients ease their thoughts of self-harm.
FAQs
What is ketamine?
Ketamine is a medicine derived from PCP. This chemical has been used safely as an anesthetic approved by the FDA since 1970 and is classified as a Dissociative Anesthetic.
Sprivato is esketamine, a nasal spray version of ketamine that is FDA approved for Treatment-Resistant Depression and Depression with Suicidal Ideation.
Ketamine has been used in the Emergency Department for rapid onset and effective pain management for minor procedures in adults and children!
Ketamine opens a neuroplastic window that no other medication used in depression can reliably produce.
This window allows:
Temporary uncoupling of the rigid thought state of cognitive entrapment—where the brain cannot imagine relief, alternative futures, or safety from pain.
Neuroplasticity with re-engagement of the prefrontal cortex (decision center) and emotional/memory/identity centers of the brain
Opportunity for meaning, choice, and self-compassion to land
Ketamine does not replace treatment; it creates access to it.
Who can benefit?
Is ketamine safe?
WHY OUTCOMES VARY (AND WHY TRAINING MATTERS)
What is Ethical Ketamine?
The Majority of the effects are temporary, and if we start to understand that the EFFECTS of the medicaitons are often labeled as SIDE EFFECTS... we actually understand that the EFFECTS will come and go. The Short term Effects include increased blood pressure and heart rate, distortions of thinking including audio and visual imagery. Short-term cognitive effects like decreased attention and impaired motor skills usually resolve within 2 hours. At the low dosing recommended for Mental Health compared to Anesthesia, this is a very well tolerated medication with an amazing safety profile. High dose and DAILY administration of this medication has been associated with bladder and urinary tract issues like ulcerative or interstitial cystitis with long-term, off-label misuse of ketamine.
Isn’t ketamine addictive?”
Unstructured use carries risk. Structured, trauma-informed, purpose-driven use reduces harm—especially compared to untreated despair.
Spravato R.E.M.S. provides a protocol to deliver ketamine with an ethical practice. This is not home based, self dosed medication. The medication is delivered to a provider that will administer (or observe) the medication and monitor the client for 120 minutes to support safest use.
Ketamine, like other psychadelic medications, is likely to cause symptoms of altered perceptions. Safety is an important part of receiving ethical ketamine.
Off-label use of Ketamine has many potential uses. The purpose of "Unlocking Ketamine for Suicidal Ideation" is focused on providing a solution for helping clients to Unlock their Brain to find HOPE when they are ready to find a new way to survive.
There’s not enough long-term data
You are correct—and that absence is a funding problem, not a failure of clinical observation. Waiting for perfect data while patients die is not neutrality. It is a decision.
The Medication Isn’t the Variable. The Delivery Is.
Outcomes vary because:
Providers are taught to avoid dissociation rather than understand it
Ethics are framed as restrictions, not responsibility
Integration is optional instead of essential
Fear replaces fluency
Avoiding dissociation does not make ketamine safer. Avoiding education does.